Cited by 167Ovarian function and disordersReproductive Biology and FertilityGenetic and Kidney Cyst Diseases

Alterations in Mitogen-Activated Protein Kinase Kinase and Extracellular Regulated Kinase Signaling in Theca Cells Contribute to Excessive Androgen Production in Polycystic Ovary Syndrome

Open access
Nelson-Degrave, Velen L., Wickenheisser, Jessica K., Hendricks, Karen L., Asano, Tomoichiro, Fujishiro, Midori, Legro, Richard S., Kimball, Scot R., Strauss, Jerome F. +1 more·2005·Molecular Endocrinology

Abstract

We have investigated the involvement of the MAPK signaling pathway in increased androgen biosynthesis and CYP17 gene expression in women with polycystic ovary syndrome (PCOS). A comparison of MAPK kinase (MEK1/2) and ERK1/2 phosphorylation in propagated normal and PCOS theca cells, revealed that MEK1/2 phosphorylation was decreased more than 70%, and ERK1/2 phosphorylation was reduced 50% in PCOS cells as compared with normal cells. Infection with dominant-negative MEK1 increased CYP17 mRNA and dehydroepiandrosterone (DHEA) abundance, whereas constitutively active MEK1 reduced DHEA production and CYP17 mRNA abundance. Similarly, the MEK inhibitor, PD98059, increased CYP17 mRNA accumulation and CYP17 promoter activity to levels observed in PCOS cells. Remarkably, in theca cells maintained in the complete absence of insulin, ERK1/2 phosphorylation was decreased in PCOS theca cells as compared with normal theca cells, and CYP17 mRNA and DHEA synthesis were increased in PCOS theca cells. These studies demonstrate that in PCOS cells reduced levels of activated MEK1/2 and ERK1/2 are correlated with increased androgen production, irrespective of the insulin concentration. These findings implicate alterations in the MAPK pathway in the pathogenesis of excessive ovarian androgen production in PCOS.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/me.2004-0178

Cites

69 of 69 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 70 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Nelson-Degrave, V. L., Wickenheisser, J. K., Hendricks, K. L., Asano, T., Fujishiro, M., Legro, R. S., Kimball, S. R., Strauss, J. F., & McAllister, J. M.
Affiliations
  • Departments of Cellular and Molecular Physiology (V.L.N.-D., J.K.W., K.L.H., S.R.K., J.M.M.), Pennsylvania 17033;
  • The University of Tokyo (JP)
  • Pennsylvania State University (US)
  • University of Pennsylvania (US)
Corresponding author
McAllister, Jan M.
Venue
Molecular Endocrinology
Published
2005-02-01
Volume
19
Issue
2
Pages
379-390
ISSN
  • 0888-8809 (ISSN-L)
  • 1944-9917
OpenAlex
W2090445204
Cited by
167
References
70
Citations by year
2026: 2 · 2025: 9 · 2024: 3 · 2023: 7 · 2022: 10 · 2021: 10 · 2020: 7 · 2019: 9 · 2018: 8 · 2017: 7 · 2016: 10 · 2015: 9 · 2014: 11 · 2013: 7 · 2012: 9
FWCI
8.12
Type
journal article
Language
en
Open access
Locations
  • Molecular Endocrinology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • University of Cincinnati
  • National Institutes of Health
  • Penn State College of Medicine
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD-34449, R01HD033852, HD 33852, U54HD034449)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Reproductive Biology and Fertility
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Kidney Cyst Diseases
Keywords
polycystic ovary syndrome, theca cells, androgen production, MAPK signaling, MEK1/2, ERK1/2 phosphorylation, CYP17, dehydroepiandrosterone, PD98059, ovarian steroidogenesis
MeSH terms
Adenoviridae, Androgens, Animals, Cell Line, Cells, Cultured, Dehydroepiandrosterone, Dose-Response Relationship, Drug, Enzyme Inhibitors, Female, Flavonoids, Genes, Dominant, Humans, Insulin, Lac Operon, Mutation, Ovary, Phosphorylation, Polycystic Ovary Syndrome, Promoter Regions, Genetic, RNA, Messenger, Steroid 17-alpha-Hydroxylase, Steroids, Theca Cells, Time Factors, Transfection, Blotting, Western, Mitogen-Activated Protein Kinase Kinases, Extracellular Signal-Regulated MAP Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review